{"abdominal pain": 2.01, "anaphylactic reaction": 3.11, "anaphylactic shock": 4.42, "ankylosing spondylitis": 27.4, "arthritis": 5.57, "bronchospasm": 2.98, "chest discomfort": 5.79, "colitis ulcerative": 12.69, "condition aggravated": 2.11, "crohn's disease": 16.8, "drug ineffective": 3.87, "drug specific antibody present": 68.38, "dyspnoea": 4.76, "eczema": 4.31, "erythema": 8.76, "face oedema": 3.16, "feeling hot": 3.37, "flushing": 13.55, "frequent bowel movements": 9.96, "haematochezia": 2.05, "hot flush": 2.23, "hyperhidrosis": 2.5, "hypersensitivity": 4.5, "hypotension": 2.19, "infusion related reaction": 23.26, "laryngospasm": 18.42, "loss of therapeutic response": 193.5, "oropharyngeal discomfort": 8.97, "oxygen saturation decreased": 3.61, "product quality issue": 4.16, "product substitution issue": 27.73, "pruritus": 2.7, "psoriasis": 18.64, "psoriasis area severity index increased": 516.99, "rash": 2.63, "rash erythematous": 2.17, "rectal haemorrhage": 4.88, "skin reaction": 3.82, "therapeutic product effect decreased": 3.86, "therapy non-responder": 12.7, "throat tightness": 5.08, "urticaria": 4.43}